Evaluation of biocompatible stabilised gelled soya bean oil nanoparticles as new hydrophobic reservoirs

References

• Abdallah DJ, Weiss RG. Organogels and low molecular mass organic gelators. Adv Mater 2000; 12(17)1237–47
   Web of Science ®Google Scholar
• Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev 2009; 61(6)428–37
   PubMed Web of Science ®Google Scholar
• Akinc A, Thomas M, Klibanov AM, Langer R. Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J Gene Med 2005; 7(5)657–63
   PubMed Web of Science ®Google Scholar
• Almeida AJ, Souto E. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv Drug Deliv Rev 2007; 59(6)478–90
   PubMed Web of Science ®Google Scholar
• Attama AA, Müller-Goymann CC. Effect of beewax modification on the lipid matrix and solid lipid nanoparticle crystallinity. Colloid Surf A 2008; 315: 189–95
   Web of Science ®Google Scholar
• Attama AA, Reichl S, Müller-Goymann CC. Diclofenac sodium delivery to the eye: In vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct. Int J Pharm 2008; 355: 307–13
   PubMed Web of Science ®Google Scholar
• Boussif O, Zanta MA, Behr JP. Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold. Gene Ther 1996; 3: 1074–80
   PubMed Web of Science ®Google Scholar
• Brioschi A, Zenga F, Zara GP, Gasco MR, Ducati A, Mauro A. Solid lipid nanoparticles: Could they help to improve the efficacy of pharmacologic treatments for brain tumors?. Neurol Res 2007; 29: 324–30
   PubMed Web of Science ®Google Scholar
• Bunjes H, Siekmann B. Manufacture, characterization and application of solid lipid nanoparticles as drug delivery system. Nanoparticulate Drug Delivery Systems, M Deleers, Y Pathak, D Thassu. Informa Healthcare, New York 2007; 213–68
   Google Scholar
• Cavalli R, Gasco MR, Chetoni P, Burgalassi S, Saettone MF. Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. Int J Pharm 2002; 238: 241–5
   PubMed Web of Science ®Google Scholar
• Chattopadhyay P, Shekunov BY, Yim D, Cipolla D, Boyd B, Farr S. Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system. Adv Drug Deliv Rev 2007; 6: 444–53
   Google Scholar
• Ferrari S, Moro E, Pettenazzo A, Behr JP, Zacchello F, Scarpa M. ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo. Gene Ther 1997; 4(10)1100–6
   PubMed Web of Science ®Google Scholar
• George M, Weiss RG. Molecular organogels. Soft matter comprised of low-molecular-mass organic gelators and organic liquids. Acc Chem Res 2006; 39: 489–97
   PubMed Web of Science ®Google Scholar
• Gill PS, Espina BM, Muggia F, Cabriales S, Tulpule A, Esplin JA, Liebman HA, Forssen E, Ross ME, Levine AM. Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. J Clin Oncol 1995; 13: 996–1003
   PubMed Web of Science ®Google Scholar
• Hamidi M, Azadi A, Rafiei P. Hydrogel nanoparticles in drug delivery. Adv Drug Deliv Rev 2009; 60(15)1638–49
   Google Scholar
• Huang X, Weiss R. Molecular organogels of the sodium salt of (R)-12-hydroxystearic acid and their templated syntheses of inorganic oxides. Tetrahedron 2007; 63: 7375–81
   Web of Science ®Google Scholar
• Jenning V, Gohla SH. Encapsulation of retinoids in solid lipid nanoparticles (SLN®). J Microenviron 2001; 18: 149–58
   PubMed Web of Science ®Google Scholar
• Jeong SY, Kwon IC, Chung H, 2000. Lipid emulsion and solid lipid nanoparticle as a gene or drug carrier. PCT Int. Appl, WO 2000006120
   Google Scholar
• Jores K, Haberland A, Wartewig S, Mäder K, Mehnert W. Solid lipid nanoparticles (SLN) and oil-loaded SLN studied by spectrofluorom-etry and Raman spectroscopy. Pharm Res 2005; 22: 1887–95
   PubMed Web of Science ®Google Scholar
• Joshi MD, Müller RH. Lipid nanoparticles for parenteral delivery of actives. Eur J Pharm Biopharm 2009; 71(2)161–72
   PubMed Web of Science ®Google Scholar
• Kirilov P, Franceschi-Messant S, Perez E, Rico-Lattes I, Bordat P, 2009a. WO Patent PCT/EP2007/060126
   Google Scholar
• Kirilov P, Gauffre F, Franceschi-Messant S, Perez E, Rico-Lattes I. Rheological characterization of a new type of colloidal dispersion based on nanoparticles of gelled oil. J Phys Chem B 2009b; 113: 11101–8
   PubMedGoogle Scholar
• Kirilov P, Lukyanova L, Franceschi-Messant S, Perier V, Perez E, Rico-Lattes I. A new type of colloidal dispersions based on nanoparticles of gelled oil. Colloids Surf A: Physicochem Eng Asp 2008; 328: 1–7
   Web of Science ®Google Scholar
• Kumar R, Katare Prakash O. Lecithin organogels as a potential phospholipid-structured system for topical drug delivery: A review. AAPS PharmSciTech 2005; 6: E298–E310
   PubMed Web of Science ®Google Scholar
• Lasic DD. Doxorubicin in sterically stabilized liposomes. Nature 1996; 380: 561–2
   PubMed Web of Science ®Google Scholar
• Li JL, Wang RY, Liu XY, Pan HH. Nanoengineering of a biocompatible organogel by thermal processing. J Phys Chem B 2009; 113(15)5011–5
   PubMedGoogle Scholar
• Lim SJ, Lee MK, Kim CK. Altered chemical and biological activities of all-trans retinoic acid incorporated in solid lipid nanoparticle powders. J Control Release 2004; 100: 53–61
   PubMed Web of Science ®Google Scholar
• Liu J, Gong T, Fu H, Wang C, Wang X, Chen Q, Zhang Q, He Q, Zhang Z. Solid lipid nanoparticles for pulmonary delivery of insulin. Int J Pharm 2008; 356: 333–44
   PubMed Web of Science ®Google Scholar
• Lu L, Weiss RG. Cholestanyl substituted quaternary ammonium salts as gelators of organic liquids. Langmuir 1995; 11: 3630–2
   Web of Science ®Google Scholar
• Mehnert W, Mäder K. Solid lipid nanoparticles: Production, characterization and applications. Adv Drug Deliv Rev 2001; 47: 165–96
   PubMed Web of Science ®Google Scholar
• Mukkamala R, Weiss RG. Physical gelation of organic fluids by anthraquinone – steroid-based molecules. Structural features influencing the properties of gels. Langmuir 1996; 12: 1474–82
   Google Scholar
• Müller RH. Colloidal carriers for controlled drug delivery and targeting – modification, characterization and in vivo distribution. CRC Press, Boca Raton 1991
   Google Scholar
• Müller RH, Olbrich C, 2000. Drug-delivery vehicle for the controlled administration of an active agent, produced from lipid matrix-medicament conjugates. PCT Int. Appl. WO 2000067800
   Google Scholar
• Müller RH, Petersen RD, Hommoss A, Pardeike J. Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv Drug Deliv Rev 2007; 59: 522–30
   PubMed Web of Science ®Google Scholar
• Murdan S, Andrysek T, Son D. Novel gels and their dispersions – oral drug delivery systems for ciclosporin. Int J Pharm 2005; 300: 113–24
   PubMed Web of Science ®Google Scholar
• Murdan S, vanden Bergh B, Gregoriadis G, Florence AT. Water-in-sorbitan monostearate organogels (water-in-oil gels). J Pharm Sci 1999; 88: 615–9
   PubMed Web of Science ®Google Scholar
• Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm 2009; 366: 170–84
   PubMed Web of Science ®Google Scholar
• Pisal S, Shelke V, Mahadik K, Kadam S. Effect of organogel components on in vitro nasal delivery of propranolol hydrochloride. AAPS PharmSciTech 2004; 5: E63
   PubMed Web of Science ®Google Scholar
• Priano L, Esposti D, Esposti R, Castagna G, De Medici C, Fraschini F, Gasco MR, Mauro A. Solid lipid nanoparticles incorporating melatonin as newmodel for sustained oral and transdermal delivery systems. J Nanosci Nanotechnol 2007; 7: 3596–601
   PubMed Web of Science ®Google Scholar
• Rogers MA, Wright AJ, Marangoni AG. Crystalline stability of self-assembled fibrillar networks of 12-hydroxystearic acid in edible oils. Food Res Int 2008; 41: 1026–34
   Web of Science ®Google Scholar
• Sarmento B, Martins S, Ferreira D, Souto EB. Oral insulin delivery by means of solid lipid nanoparticles. Int J Nanomed 2007; 2: 743–9
   PubMed Web of Science ®Google Scholar
• Schäfer-Korting M, Mehnert W, Korting HC. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev 2007; 59: 427–43
   PubMed Web of Science ®Google Scholar
• Serpe L, Catalano MG, Cavalli R, Ugazio E, Bosco O, Canaparo R, Muntoni E, Frairia R, Gasco MR, Eandi M, Zara GP. Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line. Eur J Pharm Biopharm 2004; 58: 673–80
   PubMed Web of Science ®Google Scholar
• Souto EB, Almeida AJ, Müller RH. Lipid nanoparticles (SLN®, NLC®) for cutaneous drug delivery: Structure, protection and skin effects. J Biomed Nanotechnol 2007; 3: 317–31
   Web of Science ®Google Scholar
• Terech P, Weiss RG. Low molecular mass gelators of organic liquids and the properties of their gels. Chem Rev 1997; 97(8)3133–60
   PubMed Web of Science ®Google Scholar
• Utreja S, Khopade AJ, Jain NK. Lipoprotein-mimicking biovectorized systems for methotrexate delivery. Pharm Acta Helv 1999; 73: 275–9
   PubMedGoogle Scholar
• Videira MA, Botelho MF, Santos AC, Gouveia LF, Pedroso De Lima JJ, Almeida AJ. Lymphatic uptake of pulmonary delivered radiolabelled solid lipid nanoparticles. J Drug Target 2002; 8: 607–13
   Google Scholar
• Vintiloiu A, Leroux JC. Organogels and their use in drug delivery – a review. J Control Release 2008; 125(3)179–92
   PubMed Web of Science ®Google Scholar
• Weiss RG, Terech P. Molecular Gels. Dordrecht. Springer, The Netherlands 2006
   Google Scholar
• Wen Y, Pan S, Luo X, Zhang X, Zhang W, Feng M. A biodegradable low molecular weight polyethylenimine derivative as low toxicity and efficient gene vector. Bioconjug Chem 2009; 20(2)322–32
   PubMed Web of Science ®Google Scholar
• Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev 2004; 56: 603–18
   PubMed Web of Science ®Google Scholar
• Wissing SA, Kayser O, Müller RH. Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev 2004; 56: 1257–72
   PubMed Web of Science ®Google Scholar
• Wong HL, Bendayan R, Rauth AM, Li Y, Wu XY. Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles. Adv Drug Deliv Rev 2007; 59(6)491–504
   PubMed Web of Science ®Google Scholar
• Wong HL, Bendayan R, Rauth AM, Xue HY, Babakhanian K, Wu XY. A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle (PLN) system. J Pharmacol Exp Ther 2006a; 317: 1372–81
   PubMed Web of Science ®Google Scholar
• Wong HL, Rauth AM, Bendayan R, Manias JL, Ramaswamy M, Liu Z, Erhan SZ, Wu XY. A new polymer-lipid hydrid nanoparticle, system increases cytotoxicity of doxorubicin against multidrug resistant, human breast cancer cells. Pharm Res 2006b; 23: 1574–85
   PubMed Web of Science ®Google Scholar